Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.

Clinical trial NCT03236974 · COMPLETED

Trial details

NCT number: NCT03236974
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Postmenopausal Women With ER+ HER2- Primary Breast Cancer

Start date: 2017-10-05
Primary completion: 2019-02-12
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.